ID

36289

Descripción

Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy; ODM derived from: https://clinicaltrials.gov/show/NCT02056548

Link

https://clinicaltrials.gov/show/NCT02056548

Palabras clave

  1. 30/4/19 30/4/19 -
  2. 20/9/21 20/9/21 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

30 de abril de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Lymphoma NCT02056548

Eligibility Lymphoma NCT02056548

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02056548
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years old or older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 0, 1, 2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
hodgkin's or non-hodgkins lymphomas according to the who 2008 classification
Descripción

Hodgkin Lymphoma WHO tumor classification | Non-Hodgkin Lymphoma WHO tumor classification

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019829
UMLS CUI [1,2]
C1301142
UMLS CUI [2,1]
C0024305
UMLS CUI [2,2]
C1301142
patients who received standard cytotoxic chemotherapies
Descripción

Cytotoxic Chemotherapy Standard

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C1442989
patients who finished chemotherapy (duration not exceeded 6 months) or who will finish the planned chemotherapy
Descripción

Chemotherapy Discontinued | Chemotherapy Planned To be stopped

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1301732
UMLS CUI [2,3]
C1272691
patients who achieved at least partial response and do not need further chemotherapy
Descripción

Partial response | Response | Chemotherapy Discontinued

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1521726
UMLS CUI [2]
C1704632
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1444662
hbsag (+) patients who received preemptive antiviral therapies
Descripción

Hepatitis B surface antigen positive | Antiviral Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C0280274
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
anti-hcv ab(+), hiv(+), or autoimmune hepatitis
Descripción

Hepatitis C antibody positive | HIV Seropositivity | Hepatitis, Autoimmune

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0281863
UMLS CUI [2]
C0019699
UMLS CUI [3]
C0241910
complications due to uncompensated liver cirrhosis
Descripción

Complications Due to Liver Cirrhosis Uncompensated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0023890
UMLS CUI [1,4]
C0205433
child pugh score : 10 points or more
Descripción

Child-Pugh Classification

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347612
hepatocellular carcinoma
Descripción

Liver carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2239176
patients who finish the lymphoma treatments with only radiotherapy
Descripción

Therapeutic radiology procedure Discontinued Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0024299

Similar models

Eligibility Lymphoma NCT02056548

  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT02056548
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years old or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1, 2
boolean
C1520224 (UMLS CUI [1])
Hodgkin Lymphoma WHO tumor classification | Non-Hodgkin Lymphoma WHO tumor classification
Item
hodgkin's or non-hodgkins lymphomas according to the who 2008 classification
boolean
C0019829 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C0024305 (UMLS CUI [2,1])
C1301142 (UMLS CUI [2,2])
Cytotoxic Chemotherapy Standard
Item
patients who received standard cytotoxic chemotherapies
boolean
C0677881 (UMLS CUI [1,1])
C1442989 (UMLS CUI [1,2])
Chemotherapy Discontinued | Chemotherapy Planned To be stopped
Item
patients who finished chemotherapy (duration not exceeded 6 months) or who will finish the planned chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1272691 (UMLS CUI [2,3])
Partial response | Response | Chemotherapy Discontinued
Item
patients who achieved at least partial response and do not need further chemotherapy
boolean
C1521726 (UMLS CUI [1])
C1704632 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
Hepatitis B surface antigen positive | Antiviral Therapy
Item
hbsag (+) patients who received preemptive antiviral therapies
boolean
C0149709 (UMLS CUI [1])
C0280274 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hepatitis C antibody positive | HIV Seropositivity | Hepatitis, Autoimmune
Item
anti-hcv ab(+), hiv(+), or autoimmune hepatitis
boolean
C0281863 (UMLS CUI [1])
C0019699 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
Complications Due to Liver Cirrhosis Uncompensated
Item
complications due to uncompensated liver cirrhosis
boolean
C0009566 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0023890 (UMLS CUI [1,3])
C0205433 (UMLS CUI [1,4])
Child-Pugh Classification
Item
child pugh score : 10 points or more
boolean
C2347612 (UMLS CUI [1])
Liver carcinoma
Item
hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
Therapeutic radiology procedure Discontinued Lymphoma
Item
patients who finish the lymphoma treatments with only radiotherapy
boolean
C1522449 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial